Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 496-502

  Adinolfi, Luigi E ^a   Restivo, Luciano ^a   Zampino, Rosa ^a   Guerrera, Barbara ^a   Lonardo, Amedeo ^b   Ruggiero, Laura ^a   Riello, Francesco ^c   Loria, Paola ^b   Florio, Anna ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c ASL Caserta   (Italy)

Author keywords

Carotid atherosclerosis; HCV; HOMA IR; Homocysteinemia; Liver steatosis; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERHOMOCYSTEINEMIA; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; BIOPSY; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; ITALY; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84858707788     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.051     Document Type: Article

References (32)

1. Wasley A., Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000, 20:1-16.
2. Ishizaka N., Ishizaka Y., Takahashi E., et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002, 359:133-135.
3. Ishizaka Y., Ishizaka N., Takahashi E., et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J 2003, 67:26-30.
4. Vassalle C., Masini S., Bianchi F., et al. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004, 90:565-566.
5. Targher G., Bertolini L., Padovani R., et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 2007, 46:1126-1132.
6. Völzke H., Schwahn C., Wolff B., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004, 174:99-103.
7. Arcari C.M., Nelson K.E., Netski D.M., et al. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis 2006, 43:53-56.
8. Boddi M., Abbate R., Chellini B., et al. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 2010, 47:72-75.
9. Völzke H., Robinson D.M., Kleine V., et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005, 11:1848-1853.
10. Fracanzani A.L., Burdick L., Raselli S., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 2008, 121:72-78.
11. Gastaldelli A., Kozakova M., Højlund K., et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544.
12. Adinolfi L.E., Gambardella M., Andreana A., et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001, 33:1358-1364.
13. Lonardo A., Adinolfi L.E., Loria P., et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004, 126:586-597.
14. Adinolfi L.E., Ingrosso D., Cesaro G., et al. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 2005, 41:995-1003.
15. Durante-Mangoni E., Zampino R., Marrone A., et al. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Aliment Pharmacol Ther 2006, 24:1349-1357.
16. Vidali M., Tripodi M.F., Ivaldi A., et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008, 48:399-406.
17. Jonsson J.R., Barrie H.D., O'Rourke P., et al. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C. Hepatology 2008, 48:80-87.
18. Adinolfi L.E., Restivo L., Zampino R., et al. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opin Pharmacother 2011, 12:2215-2234.
19. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. Diabet Med 1999, 16:442-443.
20. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
21. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
22. Toubol P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc Dis 2007, 23:75-80.
23. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999, 340:14-22.
24. Formgren L., Persson L., Israelsson B., et al. Ultrasound determined intima-media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb 1994, 14:261-264.
25. Simon A., Gariepy L., Chironi G., et al. Intima media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002, 20:159-169.
26. Talbott E.O., Zborowsld J.V., Boudreaux M.Y., et al. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004, 89:6061-6067.
27. Chambless L.E., Folsom A.R., Clegg L.X., et al. Carotid wall thickness is predictive of incident clinical stroke: The Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000, 151:478-487.
28. Lorenz M.W., Markus H.S., Bots M.L., et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
29. Butt A.A., Xiaoqiang W., Budoff M., et al. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 2009, 49:225-232.
30. Vivona N., Bivona G., Noto D., et al. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. Clin Biochem 2009, 42:1713-1718.
31. Oliveira C.P., Kappel C.R., Siqueira E.R., et al. Effect of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol 2011, (July). [Epub ahead of print].
32. Lonardo A., Lombardini S., Scaglioni F., et al. Hepatic steatosis and insulin resistance: does etiology make a difference. J Hepatol 2006, 44:190-196.